Bill Fitzgerald announces Google Cloud’s inaugural Cancer AI Symposium

Bill Fitzgerald, Head of Biotechnology Markets Americas, Google, shared a post on LinkedIn:

“We are excited to announce Google Cloud’s inaugural Cancer AI Symposium. Join us for a day fuelled by case-based insight and discussion as we explore the potential of this new era in cancer care together.

Where: Boston Center for the Arts
When: 30 October 2024

View the full speaker line up and secure your place – Register now.”

Douglas Flora shared the above post on LinkedIn, adding:

“Not too late to register. I am really looking forward to this one. A room full of brilliant people, dedicated to unraveling cancer once and for all. Am I that nerdy that THIS is how I choose to spend my PTO lol!?

The TensorBlack founders will be in attendance in full force: Debra Patt, Sanjay Juneja, Olalekan Ajayi, David Penberthy.

Let me know if you are attending, too.”

Additional information

Bill Fitzgerald is the Head of Biotechnology Markets for the Americas at Google Cloud, where he leads a strategy focused on delivering accelerated cloud-based scientific solutions to the rapidly evolving biotechnology sector. He is a former founder of the Life Sciences User Groups in Cambridge, MA, and currently serves as a member of the Massachusetts Biotech Council.

Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.

As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.